Join a live discussion on greener solvent choices in medicinal chemistry.
The ACS Green Chemistry Institute Pharmaceutical Roundtable (GCIPR) estimates that solvents account for 80-90% of waste streams and 75-80% of the life cycle impact in pharmaceutical manufacturing. While sustainability efforts often focus on late-stage clinical and manufacturing processes, much less attention has been paid to solvent consumption during early drug discovery and how these choices influence downstream environmental impact.
In this webinar session, expert researchers Álvaro Enríquez-García (Eli Lilly), Shazia Keily (Vertex Pharmaceuticals), and Paul Richardson (Pfizer), members of the ACS GCIPR Medicinal Chemistry focus team, present a comprehensive analysis of solvent usage across common chemical transformations, workups, and purifications in early drug discovery. Attendees will gain practical insights that help guide more sustainable solvent choices in medicinal chemistry.